High positivity of anti-CCP antibodies in patients with Down syndrome
dc.contributor.author | Nisihara R.M. | |
dc.contributor.author | Skare T.L. | |
dc.contributor.author | Silva M.B.G. | |
dc.contributor.author | Messias-Reason I.T. | |
dc.contributor.author | Oliveira N.P. | |
dc.contributor.author | Fiedler P.T. | |
dc.contributor.author | Utiyama S.R.R. | |
dc.date.accessioned | 2024-03-13T01:39:16Z | |
dc.date.available | 2024-03-13T01:39:16Z | |
dc.date.issued | 2007 | |
dc.description.abstract | The aim of the present study was to evaluate the prevalence of anti-cyclic citrullinated peptide (CCP) antibodies in patients with Down's syndrome (DS) previously tested for IgM rheumatoid factor (RF) and to correlate the results with clinical findings. Eighty-eight patients with DS previously tested for IgM-RF were divided into two groups matched for sex and age. Group A consists of 42 RF positive patients and group B of 44 RF negative patients. The presence of anti-CCP antibody was determined using a second-generation enzyme-linked immunosorbent assay. A total of 52.3% (45/86) of DS patients were positive for anti-CCP antibodies. Twenty-four patients (57.1%) of the RF positive group and 21 (47.7%) of the RF negative group presented anti-CCP circulating antibodies. The concordance between both tests was 54.6%. None of the patients had clinical evidence of rheumatoid arthritis or juvenile idiopathic arthritis. Although a high prevalence of anti-CCP antibodies was observed in DS patients, no association has been found presently with clinical disease. Careful follow-up of these patients will be necessary to clarify the real significance of these findings. © Clinical Rheumatology 2007. | |
dc.description.firstpage | 2031 | |
dc.description.issuenumber | 12 | |
dc.description.lastpage | 2035 | |
dc.description.volume | 26 | |
dc.identifier.doi | 10.1007/s10067-007-0606-1 | |
dc.identifier.issn | 0770-3198 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/37615 | |
dc.relation.ispartof | Clinical Rheumatology | |
dc.rights | Acesso Restrito | |
dc.subject.otherlanguage | Anti-CCP antibodies | |
dc.subject.otherlanguage | Down syndrome | |
dc.subject.otherlanguage | Rheumatoid arthritis | |
dc.subject.otherlanguage | Rheumatoid factor | |
dc.title | High positivity of anti-CCP antibodies in patients with Down syndrome | |
dc.type | Artigo | |
local.scopus.citations | 19 | |
local.scopus.eid | 2-s2.0-36248957581 | |
local.scopus.updated | 2024-05-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=36248957581&origin=inward |